Furthermore, studies conducted by Warren and co-workers [187] have demonstrated that in an in vivo mouse colon cancer model of liver metastasis, a significant decrease in the size of the tumor was achieved after the treatment with anti-VEGF monoclonal antibodies. Here, VEGFA is linked to neoplasm.